The UK needs patient capital but Neil Woodford is not the man to deliver it
Other fund managers are starting to reap the rewards of this much-needed area of domestic investment
Other fund managers are starting to reap the rewards of this much-needed area of domestic investment
Simon Clarke MP says study will help DC pension savers achieve financial stability in retirement
Equities manager boasted of government support for patient capital as trust struggled
Budget 2018 sought to reduce barriers to investing in illiquid UK growth businesses
Andrew Bailey says stakes are getting higher for securing the confidence of the public
DC schemes could be forced to allocate to UK start-ups
The initial public offering (IPO) of biotech company Autolus is a “step in the right direction” for Neil Woodford’s Patient Capital trust but investors should be prepared for a bumpy ride, according to Winterflood Securities.
The government has sought feedback on four EIS fund models to direct capital into knowledge-intensive companies, arguing the structure is best placed to stimulate investment into the early-stage companies.
Patient Capital Review changes implemented by the government mean Albion Capital has confirmed its VCT offers are fully subscribed at its new reduced target of £32m, shy of the £38m it initially hoped to raise.
Baillie Gifford has announced its intention to raise £250m by launching a patient capital trust that will target American companies with long-term growth prospects.
Investor interest in tax-efficient EIS funds is expected to rise despite managers being forced into higher-risk investments as a result of recent rule changes.
Symvan Capital is targeting wealth managers with the launch of its third Seed Enterprise Investment Scheme fund for tax-efficient investing in UK startups.